- Preview Available
- Scholarly Journal
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107
Nature Communications; London Vol. 16, Iss. 1, (2025): 1518.
DOI:10.1038/s41467-025-56729-6
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.




